News PhotosJan 10, 2009
Orexigen: Weight Loss Drug Contrave Meets Goals in Trial
Orexigen Therapeutics Inc. said Thursday that their experimental drug for weight loss, Contrave, met their primary and secondary goals, according to results of the first late-stage trial.
Read full story from EFluxMedia
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
Other Recent Food and Drug Administration Discussions
Search the Food and Drug Administration Forum:
Search the Food and Drug Administration Forum:
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| The controversy over E-cigarettes | 2 hr | Tired of Rud... | 71 |
| Policing cigarettes | 5 hr | Happy Conten... | 2070 |
| Whata s going on with KV Pharmaceutical? | 7 hr | Quality Ethics | 46 |
| Ask the Expert: Spinal Cord Stimulation devices | 8 hr | GREGORY ZARI... | 1 |
| Tobacco tax sways some to grow own | 8 hr | Vince Elsner | 1 |
| The FDA approves generic Ambien (Apr '07) | 10 hr | sleepless | 142 |
| Lupin Announces Final FDA Approval of Cefdinir ... (Aug '06) | 12 hr | Selena | 6 |
Scorpio
Most Popular
